van Heusden, Klaske http://orcid.org/0000-0003-2763-5279
Cooke, Erin http://orcid.org/0000-0003-2921-1701
Brodie, Sonia http://orcid.org/0000-0003-1718-3344
West, Nicholas http://orcid.org/0000-0001-8382-5136
Görges, Matthias http://orcid.org/0000-0003-2193-178X
Dumont, Guy A http://orcid.org/0000-0003-2048-4391
Ansermino, J Mark http://orcid.org/0000-0001-8427-2035
Merchant, Richard N http://orcid.org/0000-0002-8526-2477
Clinical trials referenced in this document:
Documents that mention this clinical trial
Effect of ketamine on the NeuroSENSE WAVCNS during propofol anesthesia; a randomized feasibility trial
https://doi.org/10.1007/s10877-020-00511-0
Funding for this research was provided by:
NeuroWave Systems Inc (provided loan equipment and sensors only)
Article History
Received: 27 November 2019
Accepted: 9 April 2020
First Online: 19 April 2020
Compliance with ethical standards
:
: GAD is a co-inventor of the NeuroSENSE monitor (NeuroWave Systems Inc., Cleveland, OH), GAD and JMA have consulted for NeuroWave Systems Inc. KvH, MG, GAD, JMA, and RNM are party to a licensing agreement between UBC and NeuroWave Systems Inc. for control technology. GAD, JMA, and RNM have received funds for research sponsored by NeuroWave Systems Inc. The remaining authors have no interests to declare.
: Written informed consent was obtained from all individual participants in this study.
: This study was conducted with research ethics board approval (Fraser Health Research Ethics Board, FHREB 2016-054).